Condition 1: Chronic Obstructive Pulmonary Disease. Condition 2: Chronic Obstructive Pulmonary Disease. Chronic lower respiratory diseases Chronic lower respiratory diseases
Conditions
Interventions
Intervention 1: In the experimental group, the incentive abdominal breathing device to the patient's abdomen is closed. Then to 100 times (in 10 steps) to do abdominal breathing. This means that with
Rehabilitation
Treatment - Drugs
In the experimental group, the incentive abdominal breathing device to the patient's abdomen is closed. Then to 100 times (in 10 steps) to do abdominal breathing. This means that with the expansion of
In the control group, patients one hand on his/her stomach and put other hand on chest And 100 times (in 10 steps) do abdominal breathing so that the chest have the largest and abdomen have least disp
Sponsors
Nursing School, Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: For inclusion is satisfied; Chronic obstructive pulmonary disease has been approved by a pulmonary specialist and clinical results; FEV1 less than 80 percent of the index predicted and FEV1 / FVC ratio less than 70 percent; no Signs of lung infection, according psychiatrists lung; Aged 18 to 65 years; Not having a size too large or too small; No history of chest and abdominal surgery; No history of neuromuscular disorders; Lack of heart disease. Exclusion criteria: Respiratory infection and fever while studying; Deterioration of the patient or require hospitalization for any reason; The risk of heart problems and cardiac involvement during the study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FEV1. Timepoint: Before the intervention, day 7, the end of the study (day 14). Method of measurement: registration forms spirometric indices.;FVC. Timepoint: Before the intervention, day 7, the end of the study (day 14). Method of measurement: registration forms spirometric indices.;FEV1/FVC. Timepoint: Before the intervention, day 7, the end of the study (day 14). Method of measurement: registration forms spirometric indices.;PEFR. Timepoint: Before the intervention, day 7, the end of the study (day 14). Method of measurement: registration forms spirometric indices.;MIP. Timepoint: Before the intervention, day 7, the end of the study (day 14). Method of measurement: registration forms spirometric indices.;MVV. Timepoint: Before the intervention, day 7, the end of the study (day 14). Method of measurement: registration forms spirometric indices.;Tidal volume. Timepoint: Before the intervention, day 7, the end of the study (day 14). Method of measurement: registration forms spirometric indices.;Dyspnea. Timepoint: Before the intervention, day 7, the end of the study (day 14). Method of measurement: numerical rating scale of Dyspnea.;Respiratory rate. Timepoint: Before the intervention, day 7, the end of the study (day 14). Method of measurement: registration forms spirometric indices.;Disease severity. Timepoint: Before the intervention, day 7, the end of the study (day 14). Method of measurement: copd assesment test( cat). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehdi Golmohammadi Kavaki
Mashhad School of Nursing
Outcome results
None listed